Updated results from a phase III trial of sunitinib in GIST patients (pts) for whom imatinib (IM) therapy has failed due to resistance or intolerance.
暂无分享,去创建一个
G. Demetri | J. Verweij | P. Casali | I. Judson | M. Blackstein | C. Baum | G. McArthur | C. Garrett | M. Shah | J. Li | M. Shah